Literature DB >> 6970700

[Evaluation of ulcerative colitis and Crohn's disease activity by measurement of alpha-1-antitrypsin intestinal clearance (author's transl)].

C Florent, C L'Hirondel, C Desmazures, V Giraudeaux, J J Bernier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970700

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


× No keyword cloud information.
  5 in total

Review 1.  Non-invasive investigation of inflammatory bowel disease.

Authors:  J A Tibble; I Bjarnason
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Authors:  C Cellier; T Sahmoud; E Froguel; A Adenis; J Belaiche; J F Bretagne; C Florent; M Bouvry; J Y Mary; R Modigliani
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

3.  Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.

Authors:  W Fischbach; W Becker; J Mössner; W Koch; C Reiners
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

4.  Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.

Authors:  U Karbach; K Ewe; H Dehos
Journal:  Dig Dis Sci       Date:  1985-03       Impact factor: 3.199

5.  Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion.

Authors:  A López; J Hinojosa; A Miralles; J Primo; J D Bermúdez
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.